FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37732287> ?p ?o ?g. }

• Q37732287 description "article científic" @default.
• Q37732287 description "article scientifique" @default.
• Q37732287 description "articolo scientifico" @default.
• Q37732287 description "artigo científico" @default.
• Q37732287 description "artículu científicu espublizáu en 2010" @default.
• Q37732287 description "bilimsel makale" @default.
• Q37732287 description "scientific article published on April 2010" @default.
• Q37732287 description "vedecký článok" @default.
• Q37732287 description "vetenskaplig artikel" @default.
• Q37732287 description "videnskabelig artikel" @default.
• Q37732287 description "vědecký článek" @default.
• Q37732287 description "wetenschappelijk artikel" @default.
• Q37732287 description "wissenschaftlicher Artikel" @default.
• Q37732287 description "наукова стаття, опублікована у квітні 2010" @default.
• Q37732287 description "научни чланак" @default.
• Q37732287 description "مقالة علمية نشرت في أبريل 2010" @default.
• Q37732287 name "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 name "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 name "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 type Item @default.
• Q37732287 label "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 label "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 label "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 prefLabel "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 prefLabel "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 prefLabel "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 P1433 Q37732287-5334F691-4C92-4550-AE19-4E592767A335 @default.
• Q37732287 P1476 Q37732287-9605B5A7-95DE-4AB4-90DD-4A8DCD97BFF9 @default.
• Q37732287 P2093 Q37732287-167F3551-6907-4BCC-ABA2-5E483EDD7D4B @default.
• Q37732287 P2093 Q37732287-298174D5-5F51-4E6A-8938-3524D0CE0495 @default.
• Q37732287 P2093 Q37732287-7311F198-6FCF-40F4-AC8C-1CDC1835A497 @default.
• Q37732287 P2093 Q37732287-9A5CEAFD-A9C9-4658-B4D3-0C9A792B780D @default.
• Q37732287 P2093 Q37732287-C807E128-48D9-44D6-AC55-FB6D3633FD04 @default.
• Q37732287 P2093 Q37732287-E52C067B-4836-433F-B34C-9B8DD671E847 @default.
• Q37732287 P2860 Q37732287-0CDDEEF3-71F0-4C9E-B627-EE45D19D089C @default.
• Q37732287 P2860 Q37732287-121BBE45-56BE-42FB-B4D4-100C7DDD2A1E @default.
• Q37732287 P2860 Q37732287-12AF31B1-4302-4AA8-8F71-4D5CB390D308 @default.
• Q37732287 P2860 Q37732287-177503FA-66E9-4F7D-B0B9-35ACBDC30526 @default.
• Q37732287 P2860 Q37732287-1C8B072E-C6D9-495E-8EE9-B04A91814C79 @default.
• Q37732287 P2860 Q37732287-49FDB5B5-9527-4EFB-B5B6-B9A993B8D86D @default.
• Q37732287 P2860 Q37732287-4ED340CD-4AE7-4E1F-B2E0-C544A3AAD858 @default.
• Q37732287 P2860 Q37732287-681C02A7-45A5-4669-A192-4AC16F0FD264 @default.
• Q37732287 P2860 Q37732287-71EB0ACE-3696-4001-BC18-46B2584FD88C @default.
• Q37732287 P2860 Q37732287-78024A7B-1E61-4188-81F2-DAB55B967857 @default.
• Q37732287 P2860 Q37732287-888E1746-411C-4600-9E40-03D68423ABA1 @default.
• Q37732287 P2860 Q37732287-8BD0DC94-1253-4C7B-9D7C-0CC946ECB399 @default.
• Q37732287 P2860 Q37732287-926C44C9-40B8-44DB-AF57-5F5A7F346852 @default.
• Q37732287 P2860 Q37732287-949C71E5-3E77-42B1-BB3A-5AF73A49379E @default.
• Q37732287 P2860 Q37732287-9FDF19FD-13BD-46DB-AC8F-882B8D607A75 @default.
• Q37732287 P2860 Q37732287-A33B7815-EA9D-4E1A-A2B9-69A8AA3FF370 @default.
• Q37732287 P2860 Q37732287-AD1DA186-D908-4035-936E-A85769ADC431 @default.
• Q37732287 P2860 Q37732287-B7CABD2B-2EAC-41BF-9C87-CE9954070683 @default.
• Q37732287 P2860 Q37732287-C451D2D6-FFDF-4818-8E63-DC9286E7761F @default.
• Q37732287 P2860 Q37732287-CDACD104-52EC-4853-B091-453E39BAED2A @default.
• Q37732287 P2860 Q37732287-CDFA97EB-7370-4273-9C23-0422C45DF0F5 @default.
• Q37732287 P2860 Q37732287-D0F8A3EB-D414-4387-8331-80F6B468F599 @default.
• Q37732287 P2860 Q37732287-D29CBC1C-C3BA-429D-BEBB-30DC862BB2B4 @default.
• Q37732287 P2860 Q37732287-DB5C891E-265E-4AA6-B74D-5D17EA2DF794 @default.
• Q37732287 P2860 Q37732287-EB4CDFFF-CFFB-41F8-93CA-8EDF914EE221 @default.
• Q37732287 P2860 Q37732287-EC5777B0-C7C8-41C9-B0B6-C42189C8BC30 @default.
• Q37732287 P2860 Q37732287-EFA1C0FC-591B-4F8C-9D1C-34B19D8A83D0 @default.
• Q37732287 P2860 Q37732287-F32A4D59-A16E-46FD-B40D-A75BFDB62D55 @default.
• Q37732287 P2860 Q37732287-FC8BF9CA-734B-4CBD-BDB4-8F40F9EE0087 @default.
• Q37732287 P2860 Q37732287-FD9E305C-2F93-47AA-B717-74369F7944AC @default.
• Q37732287 P304 Q37732287-7624F5D5-F199-45B1-B6CB-BFC1688F8A11 @default.
• Q37732287 P31 Q37732287-7d065cb9-f3f5-43c6-aa66-47f33f62ee2b @default.
• Q37732287 P31 Q37732287-E9689BB4-0424-447C-AED7-7123A03E7B72 @default.
• Q37732287 P356 Q37732287-9B3570B5-C1CF-457B-8D42-4F0FA390CE2E @default.
• Q37732287 P433 Q37732287-E7E085EA-2F4F-4D2A-B033-BBF5C00B6822 @default.
• Q37732287 P478 Q37732287-3084A6F1-D048-4A7E-ABD4-371B9A361624 @default.
• Q37732287 P577 Q37732287-9E46219B-0AA9-4C96-B989-D79B22091741 @default.
• Q37732287 P698 Q37732287-C828E23E-0426-48B8-AA8F-4F0897D4127F @default.
• Q37732287 P921 Q37732287-A2A0000E-103C-40C6-A840-B2D2D35D7519 @default.
• Q37732287 P356 ERA.10.30 @default.
• Q37732287 P698 20397920 @default.
• Q37732287 P1433 Q2999044 @default.
• Q37732287 P1476 "Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC." @default.
• Q37732287 P2093 "Astrid Belalcazar" @default.
• Q37732287 P2093 "Edgardo S Santos" @default.
• Q37732287 P2093 "Gelenis Domingo" @default.
• Q37732287 P2093 "Luis E Raez" @default.
• Q37732287 P2093 "Marcelo Blaya" @default.
• Q37732287 P2093 "Michel Velez" @default.
• Q37732287 P2860 Q27860881 @default.
• Q37732287 P2860 Q28278736 @default.
• Q37732287 P2860 Q29547546 @default.
• Q37732287 P2860 Q29615476 @default.
• Q37732287 P2860 Q29620301 @default.
• Q37732287 P2860 Q33345025 @default.
• Q37732287 P2860 Q33348775 @default.
• Q37732287 P2860 Q33364662 @default.
• Q37732287 P2860 Q33369267 @default.
• Q37732287 P2860 Q33371137 @default.
• Q37732287 P2860 Q34002518 @default.
• Q37732287 P2860 Q34547495 @default.
• Q37732287 P2860 Q34559274 @default.
• Q37732287 P2860 Q35044908 @default.
• Q37732287 P2860 Q36612331 @default.
• Q37732287 P2860 Q36615741 @default.
• Q37732287 P2860 Q36667452 @default.

• next